CYT
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Ed WhitfieldHouse · R · KY |
CYTCYT · Stock |
Purchase $1,001 - $15,000 |
May 14, 2015 | Apr 27, 2015 | Filing ↗ |
Whale Activity
No 13F positions in CYT among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Leonard Braden Michael10% owner | Purchase | +170.6K | $2.95 | $503K | Mar 20, 2024 | Form 4 ↗ |
| Leonard Braden Michael10% owner | Purchase | +113.8K | $3.01 | $342K | Mar 18, 2024 | Form 4 ↗ |
| Gaiero David GChief Financial Officer | Option exercise | +2,373 | $1.69 | $4K | Mar 4, 2024 | Form 4 ↗ |
| RENSCHLER MARKUS MDPresident and CEO · Director | Option exercise | +6,304 | $1.69 | $11K | Mar 4, 2024 | Form 4 ↗ |
| Gaiero David GChief Financial Officer | Option exercise | +4,746 | $1.69 | $8K | Feb 29, 2024 | Form 4 ↗ |
| Gaiero David GChief Financial Officer | Option exercise | +3,239 | $1.68 | $5K | Feb 29, 2024 | Form 4 ↗ |
| RENSCHLER MARKUS MDPresident and CEO · Director | Option exercise | +2,537 | $1.20 | $3K | Feb 29, 2024 | Form 4 ↗ |
| RENSCHLER MARKUS MDPresident and CEO · Director | Option exercise | +12.6K | $1.69 | $21K | Feb 29, 2024 | Form 4 ↗ |
| George JeanDirector | Option exercise | +14.2K | $1.69 | $24K | Feb 14, 2024 | Form 4 ↗ |
| Sands Stephen H.Director | Option exercise | +12.1K | $1.69 | $20K | Feb 9, 2024 | Form 4 ↗ |
| THERO JOHN FDirector | Option exercise | +12.8K | $1.69 | $22K | Feb 8, 2024 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Option exercise | +14.2K | $1.69 | $24K | Feb 6, 2024 | Form 4 ↗ |
| Gaiero David GChief Financial Officer | Option exercise | +2,373 | $1.69 | $4K | Dec 11, 2023 | Form 4 ↗ |
| Gaiero David GChief Financial Officer | Option exercise | +1,620 | $1.68 | $3K | Dec 11, 2023 | Form 4 ↗ |
| RENSCHLER MARKUS MDPresident and CEO · Director | Option exercise | +2,536 | $1.20 | $3K | Nov 20, 2023 | Form 4 ↗ |
| RENSCHLER MARKUS MDPresident and CEO · Director | Option exercise | +6,304 | $1.69 | $11K | Nov 20, 2023 | Form 4 ↗ |
| RENSCHLER MARKUS MDPresident and CEO · Director | Option exercise | +27.9K | $1.20 | $33K | Nov 20, 2023 | Form 4 ↗ |
| RENSCHLER MARKUS MDPresident and CEO · Director | Option exercise | +56.7K | $1.69 | $96K | Nov 20, 2023 | Form 4 ↗ |
| Gaiero David GChief Financial Officer | Option exercise | +21.4K | $1.69 | $36K | Nov 20, 2023 | Form 4 ↗ |
| Gaiero David GChief Financial Officer | Option exercise | +52.6K | $1.68 | $88K | Nov 20, 2023 | Form 4 ↗ |
Fund Holders
Funds report their holdings by CUSIP, and CYT could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming CYT as the client.
Government Contracts
No federal contract awards found for CYT.
U.S. Patents
No USPTO patent applications found for CYT.
Annual Financials
No annual XBRL figures on record for CYT. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
- 2-for-1Stock splitSep 18, 2014
- 3-for-1Stock splitJul 24, 1996
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
No 8-K filings on record.
About CYT
No company profile on record.

